2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.

Abstract

2-Chlorodeoxyadenosine, a new lymphocyte-selective, anti-neoplastic drug was administered to 18 patients with advanced chronic lymphocytic leukemia of B-cell origin. All patients were resistant to conventional treatment. A total of 44 courses of 2-chlorodeoxyadenosine were completed with minimal toxicity. An overall response rate of 55% was achieved with… (More)

Topics

3 Figures and Tables

Slides referencing similar topics